support@purchasepeptideseco.com

AC-262

Molecular formula: C18-H18-N2-O

Molar Mass: 278,3 g/mol

PubChem (CID): 11673547

Purity (HPLC): 98,6%

AC-262 is a non-steroidal drug that belongs to the class of selective androgen receptor modulators of the 5th generation. The drug has a high degree of selectivity and interacts with receptors only in muscle and bone tissues, without affecting the reproductive tissues or liver enzymes. The drug was developed to treat Alzheimer’s disease and prostate cancer.

AC-262 is used by athletes to build muscles. Its effectiveness is comparable to testosterone, but it has significantly fewer side effects.

AC-262 has an anabolic activity of 0.66 and an androgenic activity of 0.27. The anabolic index is 2.44, which allows classifying this drug as effective for building muscle mass with minimal androgenic side effects.

AC-262 properties:

  • Increases muscle mass.
  • Improves memory.
  • Minimizes the effects of dihydrotestosterone (DHT).
  • Reduces the level of luteinizing hormone (LH).

These properties of the drug can prevent prostate enlargement and cancer, the occurrence of diseases associated with high levels of testosterone, and effectively fight against Alzheimer’s disease.

The effective dosage of the drug for increasing muscle mass is 10-30 mg per day. The cycle of the drug intake is 8-12 weeks.

The long-term drug intake can lead to a decrease in testosterone levels, therefore, post-cyclic therapy (PCT) is recommended to restore it.

For research purposes only.